RYOIX Mutual Fund

RYOIX Mutual Fund (Rydex Biotechnology Fund Investor Class) is managed by Rydex Funds with $112.4M in net assets. RYOIX expense ratio is 1.38%, holding 69 positions across sectors including Health Care. Inception date: 1998-04-01.

RYOIX performance shows a YTD return of 15.20%. The 1-year return is 47.43% and the 5-year return is 5.72%. RYOIX dividend yield stands at 9.90%, paid annually.

RYOIX top holdings include Abbvie Inc. (8.2%), Amgen Inc. (5.0%), Gilead Sciences (4.5%), Nvaesrtex Pharmaceuticals Inc (4.3%), Regeneron Pharmaceuticals, Inc. (2.9%). Go to all RYOIX holdings, RYOIX sectors, or RYOIX dividends.

RYOIX can be compared against other funds. Use RYOIX overlap to find shared positions, or RYOIX vs another fund for a side-by-side view. RYOIX alternatives are available via the screener, along with tax-loss harvesting opportunities.